These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 9015331)
1. [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes. Bouchard P; Quirion R Neuroscience; 1997 Jan; 76(2):467-77. PubMed ID: 9015331 [TBL] [Abstract][Full Text] [Related]
2. Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study. Walker JM; Bowen WD; Goldstein SR; Roberts AH; Patrick SL; Hohmann AG; DeCosta B Brain Res; 1992 May; 581(1):33-8. PubMed ID: 1323368 [TBL] [Abstract][Full Text] [Related]
3. Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. Kitaichi K; Chabot JG; Moebius FF; Flandorfer A; Glossmann H; Quirion R J Chem Neuroanat; 2000 Dec; 20(3-4):375-87. PubMed ID: 11207432 [TBL] [Abstract][Full Text] [Related]
4. 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands. Ucar H; Cacciaguerra S; Spampinato S; Van derpoorten K; Isa M; Kanyonyo M; Poupaert JH Eur J Pharmacol; 1997 Sep; 335(2-3):267-73. PubMed ID: 9369382 [TBL] [Abstract][Full Text] [Related]
5. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. Gronier B; Debonnel G Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654 [TBL] [Abstract][Full Text] [Related]
6. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain. Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488 [TBL] [Abstract][Full Text] [Related]
7. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes. Nguyen VH; Kassiou M; Johnston GA; Christie MJ Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of [3H]DTG but not [3H](+)-pentazocine labeled sigma sites in mouse spinal cord by chronic morphine treatment. Kovács KJ; Larson AA Eur J Pharmacol; 1998 May; 350(1):47-52. PubMed ID: 9683013 [TBL] [Abstract][Full Text] [Related]
9. Multiple [3H]DTG binding sites in guinea pig cerebellum: evidence for the presence of non-specific binding. Basile AS; DeCosta B; Paul IA Eur J Pharmacol; 1994 Feb; 252(2):139-46. PubMed ID: 8157054 [TBL] [Abstract][Full Text] [Related]
10. Ionic zinc may function as an endogenous ligand for the haloperidol-sensitive sigma 2 receptor in rat brain. Connor MA; Chavkin C Mol Pharmacol; 1992 Sep; 42(3):471-9. PubMed ID: 1406599 [TBL] [Abstract][Full Text] [Related]
11. Binding of dexetimide and levetimide to [3H](+)pentazocine- and [3H]1,3-di(2-tolyl)guanidine-defined sigma recognition sites. DeHaven-Hudkins DL; Hudkins RL Life Sci; 1991; 49(18):PL135-9. PubMed ID: 1656155 [TBL] [Abstract][Full Text] [Related]
12. Regional variation in the ratio of sigma 1 to sigma 2 binding in rat brain. Leitner ML; Hohmann AG; Patrick SL; Walker JM Eur J Pharmacol; 1994 Jun; 259(1):65-9. PubMed ID: 7957595 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. Monnet FP; de Costa BR; Bowen WD Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358 [TBL] [Abstract][Full Text] [Related]
14. [3H]1,3-di(2-tolyl) guanidine binds to a sigma 2 receptor on Jurkat cell membranes, but sigma compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes. DeHaven-Hudkins DL; Daubert JD; Sawutz DG; Tiberio L; Baine Y Immunopharmacology; 1996 Oct; 35(1):27-39. PubMed ID: 8913792 [TBL] [Abstract][Full Text] [Related]
15. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist. Matsuno K; Nakazawa M; Okamoto K; Kawashima Y; Mita S Eur J Pharmacol; 1996 Jun; 306(1-3):271-9. PubMed ID: 8813641 [TBL] [Abstract][Full Text] [Related]
16. 1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain. Codd EE; Shank RP Eur J Pharmacol; 1992 Jul; 217(2-3):149-52. PubMed ID: 1425936 [TBL] [Abstract][Full Text] [Related]
17. [3H](+)-pentazocine binding to rat brain sigma 1 receptors. Cagnotto A; Bastone A; Mennini T Eur J Pharmacol; 1994 Jan; 266(2):131-8. PubMed ID: 8157067 [TBL] [Abstract][Full Text] [Related]
18. Discrepancies in characterization of sigma sites in the mouse central nervous system. Kovács KJ; Larson AA Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130 [TBL] [Abstract][Full Text] [Related]
19. Quantitative autoradiographic localization in rat brain of alpha 2-adrenergic and non-adrenergic I-receptor binding sites labelled by [3H]rilmenidine. King PR; Gundlach AL; Louis WJ Brain Res; 1995 Mar; 675(1-2):264-78. PubMed ID: 7796138 [TBL] [Abstract][Full Text] [Related]
20. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]